SPDYE14
Speedy protein E14
Also known as: SPD14_HUMAN, SPDYE14P
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DUD3
- Gene
- SPDYE14
- Ensembl
- ENSG00000286137
- Chromosome
- 7
- Canonical length
- 265 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable protein kinase binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
265 residues, UniProt reviewed canonical sequence.
>P0DUD3|SPDYE14
1 MGQILGKIMM SHQPQPQEER SPQRSTSGYP LQEVVDDEVL GPSAPGVDPS PPRRSLGWKR
61 KRECLDESDD EPEKELAPEP EETWVAETLC GLKMKAKRRR VSLVLPEYYE AFNRLLEDPV
121 IKRLLAWDKD LRVSDKYLLA MVIAYFSRAG LPSWQYQRIH FFLALYLAND MEEDDEAPKQ
181 NIFYFLYEET RSHIPLLSEL WFQLCRYMNP RARKNCSQIA LFRKYRFHFF CSMRCRAWVS
241 LEELEEIQAY DPEHWVWARD RAHLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPDYE14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 0.9 nTPM
Expression across tissuesHPA
Tissue
- testis: 0.9 nTPM
- liver: 0.2 nTPM
- spleen: 0.2 nTPM
- cerebellum: 0.1 nTPM
- cervix: 0.1 nTPM
- esophagus: 0.1 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- b-cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.5 nTPM
- amygdala: 0.4 nTPM
- cerebellum: 0.4 nTPM
- hippocampal formation: 0.4 nTPM
- medulla oblongata: 0.4 nTPM
- pons: 0.4 nTPM
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPDYE14 as an antibody target. Whether an autoantibody or antibody against SPDYE14 could matter depends on whether native SPDYE14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPDYE14 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPDYE14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...